Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naser Abdelhadi is active.

Publication


Featured researches published by Naser Abdelhadi.


Circulation Research | 2017

Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes

Muhammad Hammadah; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Naser Abdelhadi; Ayman Alkhoder; Malik Obideen; Pratik Pimple; Oleksiy Levantsevych; Heval Mohamed Kelli; Amit J. Shah; Yan V. Sun; Brad D. Pearce; Michael Kutner; Qi Long; Laura Ward; Yi-An Ko; Kareem Hosny Mohammed; Jue Lin; Jinying Zhao; J. Douglas Bremner; Jinhee Kim; Edmund K. Waller; Paolo Raggi; David S. Sheps; Arshed A. Quyyumi; Viola Vaccarino

Rationale: Leukocyte telomere length (LTL) is a biological marker of aging, and shorter LTL is associated with adverse cardiovascular outcomes. Reduced regenerative capacity has been proposed as a mechanism. Bone marrow–derived circulating progenitor cells are involved in tissue repair and regeneration. Objective: Main objective of this study was to examine the relationship between LTL and progenitor cells and their impact on adverse cardiovascular outcomes. Methods and Results: We measured LTL by quantitative polymerase chain reaction in 566 outpatients (age: 63±9 years; 76% men) with coronary artery disease. Circulating progenitor cells were enumerated by flow cytometry. After adjustment for age, sex, race, body mass index, smoking status, and previous myocardial infarction, a shorter LTL was associated with a lower CD34+ cell count: for each 10% shorter LTL, CD34+ levels were 5.2% lower (P<0.001). After adjustment for the aforementioned factors, both short LTL (<Q1) and low CD34+ levels (<Q1) predicted adverse cardiovascular outcomes (death, myocardial infarction, coronary revascularization, or cerebrovascular events) independently of each other, with a hazard ratio of 1.8 and 95% confidence interval of 1.1 to 2.0, and a hazard ratio of 2.1 and 95% confidence interval of 1.3 to 3.0, respectively, comparing Q1 to Q2–4. Patients who had both short LTL (<Q1) and low CD34+ cell count (<Q1) had the greatest risk of adverse outcomes (hazard ratio =3.5; 95% confidence interval, 1.7–7.1). Conclusions: Although shorter LTL is associated with decreased regenerative capacity, both LTL and circulating progenitor cell levels are independent and additive predictors of adverse cardiovascular outcomes in coronary artery disease patients. Our results suggest that both biological aging and reduced regenerative capacity contribute to cardiovascular events, independent of conventional risk factors.


Journal of Cardiovascular Electrophysiology | 2017

The association between acute mental stress and abnormal left atrial electrophysiology

Mph Wesley T. O'Neal Md; Muhammad Hammadah; Pratik Sandesara; Zakaria Almuwaqqat; Ayman Samman-Tahhan; Mohamad Mazen Gafeer; Naser Abdelhadi; Kobina Wilmot; Ibhar Al Mheid; Douglas Bremner; Michael Kutner; Elsayed Z. Soliman Md, MSc, Ms; Mscr Amit J. Shah Md; Facc Arshed A. Quyyumi Md; Viola Vaccarino

Acute stress may trigger atrial fibrillation (AF), but the underlying mechanisms are unclear. We examined if acute mental stress results in abnormal left atrial electrophysiology as detected by more negative deflection of P‐wave terminal force in lead V1 (PTFV1), a well‐known marker of AF risk.


Journal of the American Heart Association | 2018

Myocardial Ischemia and Mobilization of Circulating Progenitor Cells

Muhammad Hammadah; Ayman Samman Tahhan; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Bryan Kindya; Heval Mohamed Kelli; Wesley T. O'Neal; Pratik Sandesara; Samaah Sullivan; Zakaria Almuwaqqat; Malik Obideen; Naser Abdelhadi; Ayman Alkhoder; Pratik Pimple; Oleksiy Levantsevych; Kareem Hosny Mohammed; Lei Weng; Laurence Sperling; Amit J. Shah; Yan V. Sun; Brad D. Pearce; Michael Kutner; Laura Ward; J. Douglas Bremner; Jinhee Kim; Edmund K. Waller; Paolo Raggi; David S. Sheps; Viola Vaccarino

Background The response of progenitor cells (PCs) to transient myocardial ischemia in patients with coronary artery disease remains unknown. We aimed to investigate the PC response to exercise‐induced myocardial ischemia (ExMI) and compare it to flow mismatch during pharmacological stress testing. Methods and Results A total of 356 patients with stable coronary artery disease underwent 99mTc‐sestamibi myocardial perfusion imaging during exercise (69%) or pharmacological stress (31%). CD34+ and CD34+/chemokine (C‐X‐C motif) receptor 4 PCs were enumerated by flow cytometry. Change in PC count was compared between patients with and without myocardial ischemia using linear regression models. Vascular endothelial growth factor and stromal‐derived factor‐1α were quantified. Mean age was 63±9 years; 76% were men. The incidence of ExMI was 31% and 41% during exercise and pharmacological stress testing, respectively. Patients with ExMI had a significant decrease in CD34+/chemokine (C‐X‐C motif) receptor 4 (−18%, P=0.01) after stress that was inversely correlated with the magnitude of ischemia (r=−0.19, P=0.003). In contrast, patients without ExMI had an increase in CD34+/chemokine (C‐X‐C motif) receptor 4 (14.7%, P=0.02), and those undergoing pharmacological stress had no change. Plasma vascular endothelial growth factor levels increased (15%, P<0.001) in all patients undergoing exercise stress testing regardless of ischemia. However, the change in stromal‐derived factor‐1α level correlated inversely with the change in PC counts in those with ExMI (P=0.03), suggesting a greater decrease in PCs in those with a greater change in stromal‐derived factor‐1α level with exercise. Conclusions ExMI is associated with a significant decrease in circulating levels of CD34+/chemokine (C‐X‐C motif) receptor 4 PCs, likely attributable, at least in part, to stromal‐derived factor‐1α–mediated homing of PCs to the ischemic myocardium. The physiologic consequences of this uptake of PCs and their therapeutic implications need further investigation.


Journal of the American Heart Association | 2018

High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes

Ayman Samman Tahhan; Pratik Sandesara; Salim Hayek; Muhammad Hammadah; Ayman Alkhoder; Heval Mohamed Kelli; Matthew Topel; Wesley T. O'Neal; Nima Ghasemzadeh; Yi-An Ko; Mohamad Mazen Gafeer; Naser Abdelhadi; Fahad Choudhary; Keyur Patel; Agim Beshiri; Gillian Murtagh; Jonathan H. Kim; Peter W.F. Wilson; Leslee J. Shaw; Viola Vaccarino; Stephen E. Epstein; Laurence Sperling; Arshed A. Quyyumi

Background The associations between high‐sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value of hsTnI level for incident cardiovascular outcomes is independent of CAD severity. Methods and Results In 3087 patients (aged 63±12 years, 64% men) undergoing cardiac catheterization without evidence of acute myocardial infarction, the severity of CAD was calculated by the number of major coronary arteries with ≥50% stenosis and the Gensini score. CAD progression was assessed in a subset of 717 patients who had undergone ≥2 coronary angiograms >3 months before enrollment. Patients were followed up for incident all‐cause mortality and incident cardiovascular events. Of the total population, 11% had normal angiograms, 23% had nonobstructive CAD, 20% had 1‐vessel CAD, 20% had 2‐vessel CAD, and 26% had 3‐vessel CAD. After adjusting for age, sex, race, body mass index, smoking, hypertension, diabetes mellitus history, and renal function, hsTnI levels were independently associated with the severity of CAD measured by the Gensini score (log 2 ß=0.31; 95% confidence interval, 0.18–0.44; P<0.001) and with CAD progression (log 2 ß=0.36; 95% confidence interval, 0.14–0.58; P=0.001). hsTnI level was also a significant predictor of incident death, cardiovascular death, myocardial infarction, revascularization, and cardiac hospitalizations, independent of the aforementioned covariates and CAD severity. Conclusions Higher hsTnI levels are associated with the underlying burden of coronary atherosclerosis, more rapid progression of CAD, and higher risk of all‐cause mortality and incident cardiovascular events. Whether more aggressive treatment aimed at reducing hsTnI levels can modulate disease progression requires further investigation.


Brain Behavior and Immunity | 2018

Inflammatory response to mental stress and mental stress induced myocardial ischemia

Muhammad Hammadah; Samaah Sullivan; Brad D. Pearce; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Samman Tahhan; Wesley T. O'Neal; Malik Obideen; Ayman Alkhoder; Naser Abdelhadi; Heval Mohamed Kelli; Mohamad Mazen Ghafeer; Pratik Pimple; Pratik Sandesara; Amit J. Shah; Kareem Hosny; Laura Ward; Yi-An Ko; Yan V. Sun; Lei Weng; Michael Kutner; J. Douglas Bremner; David S. Sheps; Fabio Esteves; Paolo Raggi; Viola Vaccarino; Arshed A. Quyyumi

BACKGROUND Mental stress-induced myocardial ischemia (MSIMI) is associated with increased risk of adverse cardiovascular outcomes, yet the underlying mechanisms are not well understood. We measured the inflammatory response to acute laboratory mental stress in patients with coronary artery disease (CAD) and its association with MSIMI. We hypothesized that patients with MSIMI would have a higher inflammatory response to mental stress in comparison to those without ischemia. METHODS Patients with stable CAD underwent 99mTc sestamibi myocardial perfusion imaging during mental stress testing using a public speaking stressor. MSIMI was determined as impaired myocardial perfusion using a 17-segment model. Inflammatory markers including interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), matrix metallopeptidase 9 (MMP-9) and high-sensitivity C reactive protein (hsCRP) were measured at rest and 90 min after mental stress. Results were validated in an independent sample of 228 post-myocardial infarction patients. RESULTS Of 607 patients analyzed in this study, (mean age 63 ± 9 years, 76% male), 99 (16.3%) developed MSIMI. Mental stress resulted in a significant increase in IL-6, MCP-1, and MMP-9 (all p <0.0001), but not hsCRP. However, the changes in these markers were similar in those with and without MSIMI. Neither resting levels of these biomarkers, nor their changes with mental stress were significantly associated with MSIMI. Results in the replication sample were similar. CONCLUSION Mental stress is associated with acute increases in several inflammatory markers. However, neither the baseline inflammatory status nor the magnitude of the inflammatory response to mental stress over 90 min were significantly associated with MSIMI.


Journal of the American College of Cardiology | 2017

INFLAMMATORY RESPONSE TO MENTAL STRESS AND MENTAL STRESS INDUCED MYOCARDIAL ISCHEMIA

Muhammad Hammadah; Brad D. Pearce; Naser Abdelhadi; Mazen Ghafeer; Ayman Alkhoder; Malik Obideen; Oleksiy Levantsevych; Lie Weng; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Heval Mohamed Kelli; Wesley T. O'Neal; Ayman Samman Tahhan; Pratik Pimple; Samaah Sulivan; Pratik Sandesara; Amit J. Shah; Yan V. Sun; Doug Bremner; Raggi Paolo; Viola Vaccarino; Arshed A. Quyyumi

Background: Mental stress (MS)-induced myocardial ischemia (MSIMI) is associated with increased risk of adverse cardiovascular outcomes, yet the underlying mechanisms are not well understood. We measured the inflammatory response to acute laboratory MS in patients with CAD and its correlation with


Journal of the American College of Cardiology | 2017

ASSOCIATION BETWEEN CIRCULATING PROGENITOR CELLS AND OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE

Pratik Sandesara; Ayman Samman Tahhan; Jay Khambhati; Eric Stahl; Salim Hayek; Muhammad Hammadah; Heval Mohamed Kelli; Matthew Topel; Ayman Alkhoder; Kaavya Chivukula; Hiroshi Aida; Mohamad Mazen Gafeer; Naser Abdelhadi; Iraj Hesaroieh; Humza Naqvi; Ernestine Mahar; Edmund K. Waller; Laurence Sperling; Arshed A. Quyyumi

Background: Circulating hematopoietic enriched progenitor cells (PCs) predict adverse cardiovascular outcomes in patients with coronary artery disease (CAD). The additive predictive role of endothelial enriched PCs expressing vascular endothelial growth factor receptor (VEGF) remains controversial.


Journal of the American College of Cardiology | 2016

SHORTER TELOMERE LENGTH IS ASSOCIATED WITH LOWER LEVELS OF CIRCULATING PROGENITOR CELLS

Muhammad Hammadah; Ibhar Al Mheid; Malik Obideen; Naser Abdelhadi; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Pratik Pimple; Shuyang Fang; Mosaab Awad; Oleksiy Levantsevych; Heval Mohamed Kelli; Yasir Bouchi; Nancy Murrah; Amit J. Shah; Ernest V. Garcia; Elizabeth Blackburn; Yan V. Sun; Jinying Zhao; Jue Lin; Jinhee Kim; Edmund K. Waller; Paolo Raggi; Viola Vaccarino; Arshed A. Quyyumi

Leucocyte telomere length (LTL) is a biological marker of aging which has been associated with decreased survival. Bone marrow-derived circulating progenitor cells (CPC) are involved in vascular repair and regeneration, and reduced CPC counts are associated with poor outcomes. We sought to determine


Atherosclerosis | 2017

Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes

Ayman Samman Tahhan; Salim Hayek; Pratik Sandesara; Jamal Hajjari; Muhammad Hammadah; Wesley T. O'Neal; Heval Mohamed Kelli; Ayman Alkhoder; Nima Ghasemzadeh; Yi-An Ko; Hiroshi Aida; Mohamad Mazen Gafeer; Naser Abdelhadi; Kareem Hosny Mohammed; Keyur Patel; Shipra Arya; Jochen Reiser; Viola Vaccarino; Laurence Sperling; Arshed A. Quyyumi


Jacc-cardiovascular Imaging | 2017

Association Between High-Sensitivity Cardiac Troponin Levels and Myocardial Ischemia During Mental Stress and Conventional Stress

Muhammad Hammadah; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Malik Obideen; Naser Abdelhadi; Shuyang Fang; Ijeoma Ibeanu; Pratik Pimple; Heval Mohamed Kelli; Amit J. Shah; Brad D. Pearce; Yan V. Sun; Ernest V. Garcia; Michael Kutner; Qi Long; Laura Ward; J. Douglas Bremner; Fabio Esteves; Paolo Raggi; David S. Sheps; Viola Vaccarino; Arshed A. Quyyumi

Collaboration


Dive into the Naser Abdelhadi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge